CBD

CBD

FDA Reopens CBD Public Comment, “Extending It Indefinitely”

The Agency is specifically looking to collect “scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”

CBD, Congress

What’s in the US Food and Drug Administration’s CBD Report to Congress?

The FDA is reopening public comment, collaborating with global regulators on how to handle cannabinoids, and backing research on CBD and “dermal penetration.”

CBD, Hemp

FDA to Ag Regulators: “Fool’s Game” to Tell Americans They Can’t Use CBD Products

At NASDA Winter Policy Conference, USDA says it’s loosening DEA lab testing requirement for hemp, and FDA signals openness to non-pharma CBD products.

Business, CBD

Q&A: The Food Giants Push For “Smart Regulation” of CBD

Consumer Brands Association—think Kellogg's, Pepsi, etc.—has created a high-voltage advisory board to frame its advocacy approach.

CBD

FDA Says It “Cannot Conclude” That CBD Is Safe as a Food Additive

The CBD industry has long awaited the FDA’s regulatory approach to CBD products, which the agency says it will unveil “in the coming weeks.”

CBD, Congress

Mitch McConnell Pressures the FDA to Go Easy on Hemp-Derived CBD

The push could give CBD-based food additives and dietary supplements the green light.

CBD, Hemp

Here’s What People Want the FDA to Know About CBD

The FDA has been collecting public comments since April to inform CBD product rules, and the window closes tomorrow. From state ag regulators to New York’s Bar Association, here are some highlights.

CBD

FDA Extends Public Comment on Products Containing Cannabis

The agency, which will determine the future of the CBD industry, also provided an update on its information gathering. And yesterday, Canada’s health officials initiated a somewhat similar process.

CBD, New York

New York Lawmakers Address the CBD Sprawl

Proposed legislation isn’t intended to bypass the FDA’s forthcoming national regulations. But with CBD products already on shelves, lawmakers can’t wait.

CBD, Hemp

Hemp: “Can this stuff be smoked?”

One unintended outcomes of last year’s Farm Bill: a mini-trend in smoking hemp.

CBD

FDA Holds Historic Hearing on CBD to Shape the Future of the New Industry

"Across the United States, state and local regulators have been confronted with a huge onslaught of CBD.”

CBD

The CBD Conundrum at the FDA

Should cannabidiol be regulated as a supplement, or a drug? Is it effective? Safe? Big business waits impatiently in the wings as the agency thinks through decisions to shape a multi-billion-dollar industry.

Business, CBD

Ben & Jerry’s Jumps on CBD Wagon Just Before FDA Hearing

It’s more of an engagement and publicity stunt, but this one calls for ice cream fans to contact the FDA in support of CBD.

CBD, Hemp

Upstate New York: A “Hemp Industrial Park” Sparks Hope

Canopy Growth selected a small, struggling county for its multimillion-dollar facility to produce hemp-derived CBD products.

CBD

Outgoing FDA Commissioner Outlines Next Steps On CBD

A public meeting next month will focus on “scientific data and information about products containing cannabis or cannabis-derived compounds.”

CBD, Hemp

Outgoing FDA Commissioner Scott Gottlieb Says Rules for CBD Could Take Three Years, or Longer

Cannabis and hemp industry members have been awaiting clarity on the legality of hemp-derived CBD products following the passage of the 2018 Farm Bill that legalized hemp.